Rock Springs Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Rock Springs Capital Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-270,000	Closed	-$567K	–	154
2018 Q1	$567K	Hold	270,000	–	–	0.02%	148
2017 Q4	$548K	Hold	270,000	–	–	0.02%	143
2017 Q3	$359K	Hold	270,000	–	–	0.02%	144
2017 Q2	$424K	Hold	270,000	–	–	0.02%	146
2017 Q1	$872K	Hold	270,000	–	–	0.05%	133
2016 Q4	$365K	Hold	270,000	–	–	0.02%	131
2016 Q3	$421K	Hold	270,000	–	–	0.03%	136
2016 Q2	$359K	Hold	270,000	–	–	0.03%	137
2016 Q1	$1.42M	Buy	270,000 +55,000	+26%	+$337K	0.12%	119
2015 Q4	$1.69M	Hold	215,000	–	–	0.13%	113
2015 Q3	$1.82M	Hold	215,000	–	–	0.15%	114
2015 Q2	$2.35M	Hold	215,000	–	–	0.17%	107
2015 Q1	$3.01M	Buy	215,000 +5,000	+2%	+$76.4K	0.28%	89
2014 Q4	$3.55M	Hold	210,000	–	–	0.41%	74
2014 Q3	$2.82M	Buy	210,000 +57,500	+38%	+$685K	0.44%	67
2014 Q2	$1.94M	Buy	152,500 +55,000	+56%	+$573K	0.35%	72
2014 Q1	$1.16M	Buy	97,500 +1,500	+2%	+$20.1K	0.27%	69
2013 Q4	$1.33M	Buy	+96,000	New	+$1.36M	0.47%	53

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Rock Springs Capital Management's INFI Position: Q2 2018 in Review

Rock Springs Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2018, closing a stake of 270,000 shares — an estimated $567K sold.

Rock Springs Capital Management first reported a position in INFI in Q4 2013 and held it in 18 quarters. The position peaked at $3.55M in Q4 2014. 64 funds tracked by Wall St. Rank hold INFI as of Q2 2018.

Rock Springs Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Rock Springs Capital Management sold 270,000 Infinity Pharmaceuticals, Inc. shares in Q2 2018, an estimated $567K.
Rock Springs Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 18 quarters.
Rock Springs Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $3.55M in Q4 2014.
64 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2018.

Based on Rock Springs Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.